iCare is exhibiting its fully automatic confocal imaging solutions, including the iCare EIDON UWFL scanner and the market-leading iCare DRSplus screening solution with AI-assisted screening for DR, AMD and Glaucoma at c)optikk Høst 2026.

iCare is a trusted partner in ophthalmic technology offering medical devices to aid in screening, diagnosing and monitoring ocular diseases. Cutting-edge technology, ease of use and operational reliability are the cornerstones for the success of iCare. The medical device product line consists of retinal imaging , perimeter and microperimeter, rebound tonometers and software solutions. iCare fundus imaging devices use TrueColor Confocal Technology providing enhanced image quality from posterior pole to periphery. This combined with fully automated features makes retinal imaging fast and easy. iCare fundus perimetry is the first automated perimeter that combines visual field testing with retinal tracking and fundus imaging. This enables real-time compensation for eye movements and increased test reliability. iCare rebound tonometry uses patented technology to obtain reliable and rapid IOP measurements without the need for anesthetic drops. This trusted technology used by clinics is now available for patients to gather more IOP data at home. iCare software solutions are intuitive digital tools that facilitate efficiency and enhance continuity of care by connecting eye care pathways. iCare is a trademark of Icare Finland Oy. Icare Finland Oy, Icare USA, Inc., iCare World Australia Pty Ltd, China iCare Medical Technology Co. Ltd, Thirona Retina B.V. and CENTERVUE S.P.A., are parts of Revenio Group and represent the brand iCare. We believe ophthalmic care should be accessible, effortless and reliable. Our mission is to establish the next level of eye care.